Daxdilimab Antibody
Daxdilimab is a monoclonal antibody targeting the pDC-specific ILT7 receptor. It is a research tool for investigating pDC biology and has shown potential in preclinical studies for modulating immune responses in conditions like acute lung injury, including COVID-19-related models.
Product Specifications
Target
Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Infectious Disease & Virology
Concentration
6.21 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
